SCYX Scynexis Inc

SCYNEXIS Inc is a pharmaceutical company engaged in the discovery, development, and commercialization of novel anti-infectives to address unmet therapeutic needs.

$7.60
As of 06/23/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  05/02/2014
Outstanding shares:  20,630,750
Average volume:  1,302,763
Market cap:   $146,890,940
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    811292200
ISIN:        US8112922005
Sedol:      BMCC9R7
Valuation   (See tab for details)
PE ratio:   -31.86
PB ratio:   5.74
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy